Pamela C. Fralick, President of Innovative Medicines Canada (IMC), the innovative pharma association in Canada, looks back on her first half year in…

Dr. Ermano Buratti, General Manager for Astellas Pharma in Italy, discusses the company’s evolution as it enters its second decade, the importance…

The Thai pharmaceutical market is growing due to an aging, wealthier local population and a large medical tourism sector. International…

Country Manager of Norpharma, Denmark, discusses how the company has been able to remain a market competitor while maintaining satisfactory payer…

We last met you in 2008 as Chair of the Pharmaceuticals Industry Council (PIC), which set itself the goal of doubling the levels of exports, R&D…

In trying to be an effective association and positively influence the environment for your members, what have been the main achievements and…

Under various former names for over five decades, the Agency has undoubtedly played a key role in setting a regulatory framework for Romania’s…

APMGR is obviously a rather young association that has only really been active since about a year now. Can you first comment on the timing that the…

To begin, would you please introduce GMIA to Pharmaceutical Executive readers? The GMIA is an industry organization. Its six members are:…

To begin, would you please introduce Medicines Australia to Pharmaceutical Executive readers? Medicines Australia is the association that represents…

To begin, would you please introduce Medicines Australia to Pharmaceutical Executive readers? Medicines Australia is the national industry…

Mr. Pagdanganan, you were appointed chairman of MeTA in April, after having served as Vice Chairman of the Council. Can you please begin by giving to…